Skip to main content
Clinical Trials/NCT00390988
NCT00390988CompletedNot Applicable

Comparison of Capillary and Venous Blood Count Parameters

University of Magdeburg0 sites250 target enrollmentStarted: October 23, 2006Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
250

Study Overview

Brief Summary

The purpose of this study is to compare capillary blood count parameters with the corresponding venous samples to verify the hypothesis that capillary and venous blood count parameters are equivalent.

Detailed Description

In patients with haematological diseases regular blood count analyses are necessary. In haematology, capillary blood count analyses became established in routine diagnostics. The method and procedure of capillary blood sampling is well accepted by both the patients and the medical personal for a long time. However, only venous values are generally accepted in clinical routine. It is important to know whether or how capillary blood gives discrepant results for the various parameters. Values for therapeutic decisions, e.g. transfusion, are only known for venous values. So far, there are only deficient data available. Therefore, the aim of this study is (i) to compare capillary blood count parameters with the corresponding venous samples to verify the hypothesis that capillary and venous blood count parameters are equivalent, (ii) to include an adequate large number of adult haematological patients (with low and high values) and healthy adults, (iii) to obtain difference values for conversation of measured capillary values into the corresponding venous values.

Study Design

Study Type
Observational
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patients with haematological diseases ≥18 years
  • Healthy volunteers ≥18 years
  • Informed consent
  • No participation in another study 3 month before and during the study

Exclusion Criteria

  • Subjects <18 years
  • Healthy subjects with acute or chronic infections and autoimmune or malignant diseases

Investigators

Sponsor
University of Magdeburg
Sponsor Class
Other

Similar Trials